日本-话题@MedSci

#日本#

594篇内容 | 8350人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1294515, encodeId=5d1e129451571, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=Opdivo & Yervoy联合疗法在日本寻求治疗不可切除、晚期或复发性非小细胞肺癌, objectType=article, longId=185337, objectId=697318533ec4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=697318533ec4, replyNumber=0, likeNumber=74, createdTime=2019-12-29, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=697318533ec4, moduleTitle=Opdivo & Yervoy联合疗法在日本寻求治疗不可切除、晚期或复发性非小细胞肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=697318533ec4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294514, encodeId=5061129451490, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=2019 日本建议：正确使用SGLT-2抑制剂, objectType=article, longId=184705, objectId=d6e2184e05d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6e2184e05d3, replyNumber=0, likeNumber=0, createdTime=2019-12-14, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6e2184e05d3, moduleTitle=2019 日本建议：正确使用SGLT-2抑制剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6e2184e05d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294513, encodeId=ba72129451348, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=新药研发仅次于美国日本这33款药物只在本土上市！, objectType=article, longId=184655, objectId=0d8d1846557a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d8d1846557a, replyNumber=0, likeNumber=70, createdTime=2019-12-14, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d8d1846557a, moduleTitle=新药研发仅次于美国日本这33款药物只在本土上市！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d8d1846557a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294512, encodeId=97a21294512a9, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本研究：大笑疗法有助于减轻癌症患者痛楚, objectType=article, longId=184627, objectId=cee318462ef0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cee318462ef0, replyNumber=0, likeNumber=62, createdTime=2019-12-13, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cee318462ef0, moduleTitle=日本研究：大笑疗法有助于减轻癌症患者痛楚, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cee318462ef0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294511, encodeId=f03412945116b, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本推出慢性心衰新药——Coralan（伊伐布雷定）, objectType=article, longId=183988, objectId=7acb183988d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7acb183988d7, replyNumber=0, likeNumber=57, createdTime=2019-12-04, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7acb183988d7, moduleTitle=日本推出慢性心衰新药——Coralan（伊伐布雷定）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7acb183988d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294510, encodeId=a46a129451038, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=J Gastroenterology：日本人群腹部内脏脂肪肥胖与长节段Barrett食管之间的关联, objectType=article, longId=183878, objectId=31101838e8ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31101838e8ec, replyNumber=0, likeNumber=59, createdTime=2019-12-02, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31101838e8ec, moduleTitle=J Gastroenterology：日本人群腹部内脏脂肪肥胖与长节段Barrett食管之间的关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31101838e8ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294509, encodeId=e476129450963, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=BTK抑制剂ONO-4059寻求在日本的生产和销售许可，用于治疗华氏巨球蛋白血症和淋巴浆细胞性淋巴瘤, objectType=article, longId=183717, objectId=9ef0183e173f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ef0183e173f, replyNumber=0, likeNumber=65, createdTime=2019-11-30, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ef0183e173f, moduleTitle=BTK抑制剂ONO-4059寻求在日本的生产和销售许可，用于治疗华氏巨球蛋白血症和淋巴浆细胞性淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ef0183e173f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294508, encodeId=021d12945089f, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本厚生劳动省：授予tepotinib治疗MET基因改变的NSCLC患者的孤儿药认定, objectType=article, longId=183347, objectId=97cd18334e4f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97cd18334e4f, replyNumber=0, likeNumber=54, createdTime=2019-11-23, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97cd18334e4f, moduleTitle=日本厚生劳动省：授予tepotinib治疗MET基因改变的NSCLC患者的孤儿药认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97cd18334e4f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294507, encodeId=d72b129450e7f, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本厚生劳动省：授予Polatuzumab vedotin治疗弥漫性大B细胞淋巴瘤的孤儿药认定, objectType=article, longId=183346, objectId=525e183346c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=525e183346c6, replyNumber=0, likeNumber=76, createdTime=2019-11-23, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=525e183346c6, moduleTitle=日本厚生劳动省：授予Polatuzumab vedotin治疗弥漫性大B细胞淋巴瘤的孤儿药认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=525e183346c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294506, encodeId=434c1294506d7, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=美国FDA批准了日本盐野义制药的Fetroja，用于复杂尿路感染患者, objectType=article, longId=183116, objectId=bbbb1831162d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bbbb1831162d, replyNumber=0, likeNumber=74, createdTime=2019-11-19, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bbbb1831162d, moduleTitle=美国FDA批准了日本盐野义制药的Fetroja，用于复杂尿路感染患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bbbb1831162d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294505, encodeId=21eb12945053a, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=2019年日本高血压管理指南解读, objectType=article, longId=182532, objectId=437918253271, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=437918253271, replyNumber=0, likeNumber=49, createdTime=2019-11-08, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=437918253271, moduleTitle=2019年日本高血压管理指南解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=437918253271)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294504, encodeId=194b129450486, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=2019 日本慢性耳鸣的诊断和治疗指南, objectType=article, longId=181790, objectId=dd1d181e9073, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd1d181e9073, replyNumber=0, likeNumber=61, createdTime=2019-10-24, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd1d181e9073, moduleTitle=2019 日本慢性耳鸣的诊断和治疗指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd1d181e9073)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294503, encodeId=4f7d129450312, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=Nat Commun：日本人群全基因组关联分析鉴定了12个新的前列腺癌易感位点, objectType=article, longId=181746, objectId=3807181e4644, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3807181e4644, replyNumber=0, likeNumber=81, createdTime=2019-10-19, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3807181e4644, moduleTitle=Nat Commun：日本人群全基因组关联分析鉴定了12个新的前列腺癌易感位点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3807181e4644)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294502, encodeId=97e912945028b, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本京都大学成功用芯片锁定肺癌患处实施手术, objectType=article, longId=181392, objectId=ec6f1813923b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec6f1813923b, replyNumber=0, likeNumber=82, createdTime=2019-10-18, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec6f1813923b, moduleTitle=日本京都大学成功用芯片锁定肺癌患处实施手术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec6f1813923b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294501, encodeId=8d1e129450100, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本东海村核临界事故——治疗核辐射83天的记录, objectType=article, longId=180661, objectId=ad78180661e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad78180661e2, replyNumber=0, likeNumber=76, createdTime=2019-10-10, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad78180661e2, moduleTitle=日本东海村核临界事故——治疗核辐射83天的记录, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad78180661e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294500, encodeId=53c9129450076, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本进行首例再编程干细胞角膜手术, objectType=article, longId=180369, objectId=1c89180369a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c89180369a6, replyNumber=0, likeNumber=81, createdTime=2019-10-02, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c89180369a6, moduleTitle=日本进行首例再编程干细胞角膜手术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c89180369a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294499, encodeId=b8fa129449957, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=Nature：日本再生医学的“商业繁荣”，令人担忧, objectType=article, longId=180301, objectId=3c0d1803015d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c0d1803015d, replyNumber=0, likeNumber=71, createdTime=2019-10-01, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c0d1803015d, moduleTitle=Nature：日本再生医学的“商业繁荣”，令人担忧, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c0d1803015d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294498, encodeId=2b96129449848, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=理想的中药出口日本欧洲，绝大部分中国人吃不到, objectType=article, longId=179968, objectId=b4311e99689a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4311e99689a, replyNumber=0, likeNumber=77, createdTime=2019-09-26, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4311e99689a, moduleTitle=理想的中药出口日本欧洲，绝大部分中国人吃不到, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4311e99689a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294497, encodeId=26d8129449e76, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本7万人18年追踪研究：多吃豆腐，少吃红肉，可长寿！, objectType=article, longId=179777, objectId=abed1e977773, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abed1e977773, replyNumber=0, likeNumber=60, createdTime=2019-09-22, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abed1e977773, moduleTitle=日本7万人18年追踪研究：多吃豆腐，少吃红肉，可长寿！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abed1e977773)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294496, encodeId=8e2212944964e, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本厚劳省计划活用医疗健康数据解析基因信息, objectType=article, longId=179586, objectId=74891e958668, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74891e958668, replyNumber=0, likeNumber=45, createdTime=2019-09-18, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74891e958668, moduleTitle=日本厚劳省计划活用医疗健康数据解析基因信息, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74891e958668)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

日本

2020-05-29

医者仁心 (审核中...)

前往app查看评论内容

#日本#

Opdivo & Yervoy联合疗法在日本寻求治疗不可切除、晚期或复发性非小细胞肺癌

2019-12-29

医者仁心 (审核中...)

前往app查看评论内容

#日本#

2019 日本建议：正确使用SGLT-2抑制剂

2019-12-14

医者仁心 (审核中...)

前往app查看评论内容

#日本#

新药研发仅次于美国日本这33款药物只在本土上市！

2019-12-14

医者仁心 (审核中...)

前往app查看评论内容

#日本#

日本研究：大笑疗法有助于减轻癌症患者痛楚

2019-12-13

医者仁心 (审核中...)

前往app查看评论内容

#日本#

日本推出慢性心衰新药——Coralan（伊伐布雷定）

2019-12-04

医者仁心 (审核中...)

前往app查看评论内容

#日本#

J Gastroenterology：日本人群腹部内脏脂肪肥胖与长节段Barrett食管之间的关联

2019-12-02

chentianping (审核中...)

前往app查看评论内容

#日本#

BTK抑制剂ONO-4059寻求在日本的生产和销售许可，用于治疗华氏巨球蛋白血症和淋巴浆细胞性淋巴瘤

2019-11-30

chentianping (审核中...)

前往app查看评论内容

#日本#

日本厚生劳动省：授予tepotinib治疗MET基因改变的NSCLC患者的孤儿药认定

2019-11-23

chentianping (审核中...)

前往app查看评论内容

#日本#

日本厚生劳动省：授予Polatuzumab vedotin治疗弥漫性大B细胞淋巴瘤的孤儿药认定

2019-11-23

chentianping (审核中...)

前往app查看评论内容

#日本#

美国FDA批准了日本盐野义制药的Fetroja，用于复杂尿路感染患者

2019-11-19

chentianping (审核中...)

前往app查看评论内容

#日本#

2019年日本高血压管理指南解读

2019-11-08

chentianping (审核中...)

前往app查看评论内容

#日本#

2019 日本慢性耳鸣的诊断和治疗指南

2019-10-24

chentianping (审核中...)

前往app查看评论内容

#日本#

Nat Commun：日本人群全基因组关联分析鉴定了12个新的前列腺癌易感位点

2019-10-19

chentianping (审核中...)

前往app查看评论内容

#日本#

日本京都大学成功用芯片锁定肺癌患处实施手术

2019-10-18

chentianping (审核中...)

前往app查看评论内容

#日本#

日本东海村核临界事故——治疗核辐射83天的记录

2019-10-10

chentianping (审核中...)

前往app查看评论内容

#日本#

日本进行首例再编程干细胞角膜手术

2019-10-02

chentianping (审核中...)

前往app查看评论内容

#日本#

Nature：日本再生医学的“商业繁荣”，令人担忧

2019-10-01

chentianping (审核中...)

前往app查看评论内容

#日本#

理想的中药出口日本欧洲，绝大部分中国人吃不到

2019-09-26

chentianping (审核中...)

前往app查看评论内容

#日本#

日本7万人18年追踪研究：多吃豆腐，少吃红肉，可长寿！

2019-09-22

chentianping (审核中...)

前往app查看评论内容

#日本#

日本厚劳省计划活用医疗健康数据解析基因信息

2019-09-18

科室
- - 订阅+
  - 更多科室
工具
服务